[HTML][HTML] Immunology of COVID-19: current state of the science
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting …
syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting …
Clinical and translational values of spatial transcriptomics
L Zhang, D Chen, D Song, X Liu, Y Zhang… - … and Targeted Therapy, 2022 - nature.com
The combination of spatial transcriptomics (ST) and single cell RNA sequencing (scRNA-
seq) acts as a pivotal component to bridge the pathological phenomes of human tissues with …
seq) acts as a pivotal component to bridge the pathological phenomes of human tissues with …
Increased incidence of barotrauma in patients with COVID-19 on invasive mechanical ventilation
Background A high number of patients with coronavirus disease 2019 (COVID-19)
pneumonia who had barotrauma related to invasive mechanical ventilation at the authors' …
pneumonia who had barotrauma related to invasive mechanical ventilation at the authors' …
Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia: JACC Focus Seminar
The cardiovascular system is affected broadly by severe acute respiratory syndrome
coronavirus 2 infection. Both direct viral infection and indirect injury resulting from …
coronavirus 2 infection. Both direct viral infection and indirect injury resulting from …
Pulmonary thrombosis and thromboembolism in COVID-19
HD Poor - Chest, 2021 - Elsevier
COVID-19, the disease responsible for the devastating pandemic that began at the end of
2019, has been associated with a significantly increased risk of pulmonary thrombosis, even …
2019, has been associated with a significantly increased risk of pulmonary thrombosis, even …
Cellular and molecular pathways of COVID-19 and potential points of therapeutic intervention
JP Hussman - Frontiers in pharmacology, 2020 - frontiersin.org
With the objective of linking early findings relating to the novel SARS-CoV-2 coronavirus
with potentially informative findings from prior research literature and to promote …
with potentially informative findings from prior research literature and to promote …
Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: an …
X Xu, W Jiang, L Chen, Z Xu, Q Zhang… - Clinical and …, 2021 - Wiley Online Library
Abstract The coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) was identified in December 2019 and has …
syndrome coronavirus 2 (SARS‐CoV‐2) was identified in December 2019 and has …
[HTML][HTML] A proposal for staging COVID‐19 coagulopathy
Abstract Coronavirus disease 2019 (COVID‐19) is associated with significant
hypercoagulability. However, despite prophylactic anticoagulation, critically ill patients with …
hypercoagulability. However, despite prophylactic anticoagulation, critically ill patients with …
COVID-19—lessons learned and questions remaining
In this article, the editors of Clinical Infectious Diseases review some of the most important
lessons they have learned about the epidemiology, clinical features, diagnosis, treatment …
lessons they have learned about the epidemiology, clinical features, diagnosis, treatment …
[HTML][HTML] Potential role of statins in COVID-19
Patients with COVID-19 infection have an increased risk of cardiovascular complications
and thrombotic events. Statins are known for their pleiotropic anti-inflammatory …
and thrombotic events. Statins are known for their pleiotropic anti-inflammatory …